Search

Your search keyword '"Creutzfeldt-Jakob Disease"' showing total 9,517 results

Search Constraints

Start Over You searched for: Descriptor "Creutzfeldt-Jakob Disease" Remove constraint Descriptor: "Creutzfeldt-Jakob Disease"
9,517 results on '"Creutzfeldt-Jakob Disease"'

Search Results

1. A Systematic Review of Sporadic Creutzfeldt-Jakob Disease: Pathogenesis, Diagnosis, and Therapeutic Attempts.

2. Insufficient evidence for an association between iatrogenic Alzheimer's disease and cadaveric pituitary‐derived growth hormone.

4. Prion diseases disrupt glutamate/glutamine metabolism in skeletal muscle.

5. Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity?

6. Creutzfeldt-Jakob disease presenting as psychiatric disorder: case presentation and systematic review.

7. Syntaxin-6 delays prion protein fibril formation and prolongs the presence of toxic aggregation intermediates.

8. An 8-Year 5-Month-Old Boy with a Basal Ganglia Lesion with Triphasic Waves on Electroencephalogram.

9. Screening of Anti-Prion Compounds Using the Protein Misfolding Cyclic Amplification Technology.

10. Correlating Histopathological Microscopic Images of Creutzfeldt–Jakob Disease with Clinical Typology Using Graph Theory and Artificial Intelligence.

11. Creutzfeldt–Jakob Disease and Fatal Familial Insomnia: Demographics and In-Hospital Mortality in Spain.

12. Clinical Application of Blood Biomarkers in Neurodegenerative Diseases—Present and Future Perspectives.

13. Cerebrospinal fluid p‐tau181, 217, and 231 in definite Creutzfeldt–Jakob disease with and without concomitant pathologies.

14. A Systematic Review of Sporadic Creutzfeldt-Jakob Disease: Pathogenesis, Diagnosis, and Therapeutic Attempts

15. Correlating Histopathological Microscopic Images of Creutzfeldt–Jakob Disease with Clinical Typology Using Graph Theory and Artificial Intelligence

16. The diagnosis of Creutzfeldt–Jakob disease in a SARS-CoV-2-infected patient should be confirmed by brain biopsy or autopsy

17. Unmet needs of biochemical biomarkers for human prion diseases

18. Genome wide association study of clinical duration and age at onset of sporadic CJD.

19. Modulating the aggregation of human prion protein PrP106–126 by an indole-based cyclometallated palladium complex.

20. Neuropathologically directed profiling of PRNP somatic and germline variants in sporadic human prion disease.

21. Evaluation and Limitations of the Novel Chemiluminescent Enzyme Immunoassay Technique for Measuring Total Tau Protein in the Cerebrospinal Fluid of Patients with Human Prion Disease: A 10-Year Prospective Study (2011–2020).

22. Assessment of the Zoonotic Potential of Atypical Scrapie Prions in Humanized Mice Reveals Rare Phenotypic Convergence but Not Identity With Sporadic Creutzfeldt-Jakob Disease Prions.

23. Post-translational modifications in prion diseases.

24. Characterisation of RT-QuIC negative cases from the UK National CJD Research and Surveillance programme.

25. 18F‐FDG PET/CT in early phase of sporadic Creutzfeldt‐Jacob disease: A case report.

26. Heidenhain variant of Creutzfeldt-Jakob disease masquerading as neuromyelitis optica spectrum disorder: recognizing when apheresis is not the answer.

27. Novel diagnostic and prognostic approach for rapidly progressive dementias: Indicators based on amyloid/tau/neurodegeneration (ATN) framework.

28. Advancing surgical instrument safety: A screen of oxidative and alkaline prion decontaminants using real-time quaking-induced conversion with prion-coated steel beads as surgical instrument mimetic.

29. Creutzfeldt-Jakob disease in a man surviving COVID-19: disentangling a casual or causal association by neuropathology.

30. Has the frequency of ABO RhD blood groups in Australian blood donors changed as a result of the removal of the variant Creutzfeldt–Jakob disease‐based deferral?

31. Absence of evidence of transfusion transmission risk of Creutzfeldt‐Jakob disease in the United States: Results froma 28‐year lookback study.

32. Creutzfeldt–Jakob Disease Associated with E200K Mutation and SARS-CoV-2 Infection: Pure Coincidence or Neurodegenerative Acceleration?

33. Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt–Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia.

34. Interactions between Cytokines and the Pathogenesis of Prion Diseases: Insights and Implications.

35. Sporadic Creutzfeldt-Jakob disease in adults over 80 years: a 10-year review of United Kingdom surveillance.

36. A Comparison of RML Prion Inactivation Efficiency by Heterogeneous and Homogeneous Photocatalysis.

38. Complicated symptomatology and diagnosis of Creuzfeld-Jakob disease on a basis of clinical case

39. Genetic insights into drug targets for sporadic Creutzfeldt-Jakob disease: Integrative multi-omics analysis

40. The diagnosis of Creutzfeldt–Jakob disease in a SARS-CoV-2-infected patient should be confirmed by brain biopsy or autopsy.

41. A Case of Creutzfeldt–Jakob disease with psychiatric presentation

43. Validation of the 2017 International Creutzfeldt-Jakob Disease Surveillance Network diagnostic criteria for sporadic Creutzfeldt-Jakob disease

45. A case report on Creutzfeldt-Jacob disease: early diagnosis through multidisciplinary lens.

46. The Role of PET Imaging in Patients with Prion Disease: A Literature Review.

47. Anti-prion drugs do not improve survival in novel knock-in models of inherited prion disease.

48. Brain Organoids: A Game-Changer for Drug Testing.

49. Klinik und Diagnostik humaner spongiformer Enzephalopathien: ein Update.

50. Efficient transmission of human prion diseases to a glycan-free prion protein-expressing host.

Catalog

Books, media, physical & digital resources